Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

ANTXANTX
12 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in AN2 THERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. previously held 0 shares of ANTX (AN2 THERAPEUTICS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$55.3M

Total Shares Change

-3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$1.41
0
2024-Q3
Decreased
2M
-64.0%
$2.1M0.0%$1.06
0
2024-Q2
Unchanged
5.6M
0.0%
$11.9M0.2%$2.15
0
2024-Q1
Unchanged
5.6M
0.0%
$18M0.2%$3.25
0
2023-Q4
Unchanged
5.6M
0.0%
$113.7M1.8%$20.49
0
2023-Q3
Increased
5.6M
+47.1%
$89.3M1.8%$16.08
64
2023-Q2
Unchanged
3.8M
0.0%
$32.1M0.6%$8.40
0
2023-Q1
Unchanged
3.8M
0.0%
$37.2M0.8%$9.63
0
2022-Q4
Unchanged
3.8M
0.0%
$36M0.7%$9.53
0
2022-Q3
Increased
3.8M
+0.7%
$65.6M1.4%$15.32
47
2022-Q2
Increased
3.7M
+2.2%
$29.1M0.8%$7.91
41
2022-Q1
New
3.7M
-
$55.3M1.2%$15.00
67

Other major holders of ANTX: CITADEL ADVISORS LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used